Market Analysis and Insights:
In 2020, the global Blood Plasma Fractionation market size was US$ 26384 million and it is expected to reach US$ 44034 million by the end of 2027, with a CAGR of 7.63% between 2021 and 2027.
Scope and Market Size:
The global Blood Plasma Fractionation market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Blood Plasma Fractionation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
By Company
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
Segment by Type
- Albumin
- Immune Globulin
- Coagulation Factor
- Other
Segment by Application
- Hospital
- Retail Pharmacy
- Other
By Region
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Southeast Asia
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
TABLE OF CONTENTS
1 BLOOD PLASMA FRACTIONATION MARKET OVERVIEW
- 1.1 Blood Plasma Fractionation Product Overview
- 1.2 Blood Plasma Fractionation Market Segment by Type
- 1.2.1 Albumin
- 1.2.2 Immune Globulin
- 1.2.3 Coagulation Factor
- 1.3 Global Blood Plasma Fractionation Market Size by Type
- 1.3.1 Global Blood Plasma Fractionation Market Size Overview by Type (2016-2027)
- 1.3.2 Global Blood Plasma Fractionation Historic Market Size Review by Type (2016-2021)
- 1.3.2.1 Global Blood Plasma Fractionation Sales Breakdown in Volume, by Type (2016-2021)
- 1.3.2.2 Global Blood Plasma Fractionation Sales Breakdown in Value, by Type (2016-2021)
- 1.3.2.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Type (2016-2021)
- 1.3.3 Global Blood Plasma Fractionation Forecasted Market Size by Type (2022-2027)
- 1.3.3.1 Global Blood Plasma Fractionation Sales Breakdown in Volume by Type (2022-2027)
- 1.3.3.2 Global Blood Plasma Fractionation Sales Breakdown in Value by Type (2022-2027)
- 1.3.3.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Type (2022-2027)
- 1.4 Key Regions Market Size Segment by Type
- 1.4.1 North America Blood Plasma Fractionation Sales Breakdown by Type (2016-2021)
- 1.4.2 Europe Blood Plasma Fractionation Sales Breakdown by Type (2016-2021)
- 1.4.3 Asia-Pacific Blood Plasma Fractionation Sales Breakdown by Type (2016-2021)
- 1.4.4 South America Blood Plasma Fractionation Sales Breakdown by Type (2016-2021)
- 1.4.5 Middle East and Africa Blood Plasma Fractionation Sales Breakdown by Type (2016-2021)
2 BLOOD PLASMA FRACTIONATION MARKET COMPETITION BY COMPANY
- 2.1 Global Top Players by Blood Plasma Fractionation Sales (2019-2021)
- 2.2 Global Top Players by Blood Plasma Fractionation Revenue (2019-2021)
- 2.3 Global Top Players by Blood Plasma Fractionation Price (2019-2021)
- 2.4 Global Top Manufacturers Blood Plasma Fractionation Manufacturing Base Distribution, Sales Area, Product Type
- 2.5 Blood Plasma Fractionation Market Competitive Situation and Trends
- 2.5.1 Blood Plasma Fractionation Market Concentration Rate (2019-2021)
- 2.5.2 Global 5 Largest Manufacturers by Blood Plasma Fractionation Sales and Revenue in 2020
- 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Fractionation as of 2020)
- 2.7 Founded Date of Key Blood Plasma Fractionation Manufacturers
- 2.8 Key Manufacturers Blood Plasma Fractionation Product Offered
- 2.9 Mergers & Acquisitions, Expansion
3 BLOOD PLASMA FRACTIONATION STATUS AND OUTLOOK BY REGION
- 3.1 Global Blood Plasma Fractionation Market Size and CAGR by Region: 2016 VS 2021 VS 2026
- 3.2 Global Blood Plasma Fractionation Historic Market Size by Region
- 3.2.1 Global Blood Plasma Fractionation Sales in Volume by Region (2016-2021)
- 3.2.2 Global Blood Plasma Fractionation Sales in Value by Region (2016-2021)
- 3.2.3 Global Blood Plasma Fractionation Sales (Volume & Value), Price and Gross Margin (2016-2021)
- 3.3 Global Blood Plasma Fractionation Forecasted Market Size by Region
- 3.3.1 Global Blood Plasma Fractionation Sales in Volume by Region (2022-2027)
- 3.3.2 Global Blood Plasma Fractionation Sales in Value by Region (2022-2027)
- 3.3.3 Global Blood Plasma Fractionation Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 BLOOD PLASMA FRACTIONATION BY APPLICATION
- 4.1 Blood Plasma Fractionation Market Segment by Application
- 4.1.1 Hospital
- 4.1.2 Retail Pharmacy
- 4.2 Global Blood Plasma Fractionation Market Size by Application
- 4.2.1 Global Blood Plasma Fractionation Market Size Overview by Application (2016-2027)
- 4.2.2 Global Blood Plasma Fractionation Historic Market Size Review by Application (2016-2021)
- 4.2.2.1 Global Blood Plasma Fractionation Sales Breakdown in Volume, by Application (2016-2021)
- 4.2.2.2 Global Blood Plasma Fractionation Sales Breakdown in Value, by Application (2016-2021)
- 4.2.2.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Application (2016-2021)
- 4.2.3 Global Blood Plasma Fractionation Forecasted Market Size by Application (2022-2027)
- 4.2.3.1 Global Blood Plasma Fractionation Sales Breakdown in Volume by Application (2022-2027)
- 4.2.3.2 Global Blood Plasma Fractionation Sales Breakdown in Value by Application (2022-2027)
- 4.2.3.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Application (2022-2027)
- 4.3 Key Regions Market Size Segment by Application
- 4.3.1 North America Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021)
- 4.3.2 Europe Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021)
- 4.3.3 Asia-Pacific Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021)
- 4.3.4 South America Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021)
- 4.3.5 Middle East and Africa Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021)
5 NORTH AMERICA BLOOD PLASMA FRACTIONATION BY COUNTRY
- 5.1 North America Blood Plasma Fractionation Historic Market Size by Country
- 5.1.1 North America Blood Plasma Fractionation Sales in Volume by Country (2016-2021)
- 5.1.2 North America Blood Plasma Fractionation Sales in Value by Country (2016-2021)
- 5.2 North America Blood Plasma Fractionation Forecasted Market Size by Country
- 5.2.1 North America Blood Plasma Fractionation Sales in Volume by Country (2022-2027)
- 5.2.2 North America Blood Plasma Fractionation Sales in Value by Country (2022-2027)
6 EUROPE BLOOD PLASMA FRACTIONATION BY COUNTRY
- 6.1 Europe Blood Plasma Fractionation Historic Market Size by Country
- 6.1.1 Europe Blood Plasma Fractionation Sales in Volume by Country (2016-2021)
- 6.1.2 Europe Blood Plasma Fractionation Sales in Value by Country (2016-2021)
- 6.2 Europe Blood Plasma Fractionation Forecasted Market Size by Country
- 6.2.1 Europe Blood Plasma Fractionation Sales in Volume by Country (2022-2027)
- 6.2.2 Europe Blood Plasma Fractionation Sales in Value by Country (2022-2027)
7 ASIA-PACIFIC BLOOD PLASMA FRACTIONATION BY REGION
- 7.1 Asia-Pacific Blood Plasma Fractionation Historic Market Size by Region
- 7.1.1 Asia-Pacific Blood Plasma Fractionation Sales in Volume by Region (2016-2021)
- 7.1.2 Asia-Pacific Blood Plasma Fractionation Sales in Value by Region (2016-2021)
- 7.2 Asia-Pacific Blood Plasma Fractionation Forecasted Market Size by Region
- 7.2.1 Asia-Pacific Blood Plasma Fractionation Sales in Volume by Region (2022-2027)
- 7.2.2 Asia-Pacific Blood Plasma Fractionation Sales in Value by Region (2022-2027)
8 SOUTH AMERICA BLOOD PLASMA FRACTIONATION BY COUNTRY
- 8.1 South America Blood Plasma Fractionation Historic Market Size by Country
- 8.1.1 South America Blood Plasma Fractionation Sales in Volume by Country (2016-2021)
- 8.1.2 South America Blood Plasma Fractionation Sales in Value by Country (2016-2021)
- 8.2 South America Blood Plasma Fractionation Forecasted Market Size by Country
- 8.2.1 South America Blood Plasma Fractionation Sales in Volume by Country (2022-2027)
- 8.2.2 South America Blood Plasma Fractionation Sales in Value by Country (2022-2027)
9 MIDDLE EAST AND AFRICA BLOOD PLASMA FRACTIONATION BY COUNTRY
- 9.1 Middle East and Africa Blood Plasma Fractionation Historic Market Size by Country
- 9.1.1 Middle East and Africa Blood Plasma Fractionation Sales in Volume by Country (2016-2021)
- 9.1.2 Middle East and Africa Blood Plasma Fractionation Sales in Value by Country (2016-2021)
- 9.2 Middle East and Africa Blood Plasma Fractionation Forecasted Market Size by Country
- 9.2.1 Middle East and Africa Blood Plasma Fractionation Sales in Volume by Country (2022-2027)
- 9.2.2 Middle East and Africa Blood Plasma Fractionation Sales in Value by Country (2022-2027)
10 COMPANY PROFILES AND KEY FIGURES IN BLOOD PLASMA FRACTIONATION BUSINESS
- 10.1 Takeda
- 10.1.1 Takeda Company Information
- 10.1.2 Takeda Blood Plasma Fractionation Product Offered
- 10.1.3 Takeda Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
- 10.1.4 Takeda Main Business Overview
- 10.1.5 Takeda Latest Developments
- 10.2 CSL
- 10.2.1 CSL Company Information
- 10.2.2 CSL Blood Plasma Fractionation Product Offered
- 10.2.3 CSL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
- 10.2.4 CSL Main Business Overview
- 10.2.5 CSL Latest Developments
- 10.3 Grifols
- 10.3.1 Grifols Company Information
- 10.3.2 Grifols Blood Plasma Fractionation Product Offered
- 10.3.3 Grifols Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
- 10.3.4 Grifols Main Business Overview
- 10.3.5 Grifols Latest Developments
- 10.4 Octapharma
- 10.4.1 Octapharma Company Information
- 10.4.2 Octapharma Blood Plasma Fractionation Product Offered
- 10.4.3 Octapharma Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
- 10.4.4 Octapharma Main Business Overview
- 10.4.5 Octapharma Latest Developments
- 10.5 Kedrion
- 10.5.1 Kedrion Company Information
- 10.5.2 Kedrion Blood Plasma Fractionation Product Offered
- 10.5.3 Kedrion Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
- 10.5.4 Kedrion Main Business Overview
- 10.6 LFB Group
- 10.6.1 LFB Group Company Information
- 10.6.2 LFB Group Blood Plasma Fractionation Product Offered
- 10.6.3 LFB Group Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
- 10.6.4 LFB Group Main Business Overview
- 10.7 Biotest
- 10.7.1 Biotest Company Information
- 10.7.2 Biotest Blood Plasma Fractionation Product Offered
- 10.7.3 Biotest Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
- 10.7.4 Biotest Main Business Overview
- 10.8 BPL
- 10.8.1 BPL Company Information
- 10.8.2 BPL Blood Plasma Fractionation Product Offered
- 10.8.3 BPL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
- 10.8.4 BPL Main Business Overview
- 10.8.5 BPL Latest Developments
- 10.9 RAAS
- 10.9.1 RAAS Company Information
- 10.9.2 RAAS Blood Plasma Fractionation Product Offered
- 10.9.3 RAAS Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
- 10.9.4 RAAS Main Business Overview
- 10.9.5 RAAS Latest Developments
- 10.10 CBPO
- 10.10.1 CBPO Company Information
- 10.10.2 CBPO Blood Plasma Fractionation Product Offered
- 10.10.3 CBPO Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
- 10.10.4 CBPO Main Business Overview
- 10.10.5 CBPO Latest Developments
- 10.11 Hualan Bio
- 10.11.1 Hualan Bio Company Information
- 10.11.2 Hualan Bio Blood Plasma Fractionation Product Offered
- 10.11.3 Hualan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
- 10.11.4 Hualan Bio Main Business Overview
- 10.12 Tiantan Bio
- 10.12.1 Tiantan Bio Corporation Information
- 10.12.2 Tiantan Bio Blood Plasma Fractionation Products Offered
- 10.12.3 Tiantan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
- 10.12.4 Tiantan Bio Main Business Overview
- 10.13 Shuanglin Bio
- 10.13.1 Shuanglin Bio Corporation Information
- 10.13.2 Shuanglin Bio Blood Plasma Fractionation Products Offered
- 10.13.3 Shuanglin Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
- 10.13.4 Shuanglin Bio Main Business Overview
- 10.14 Boya Bio
- 10.14.1 Boya Bio Corporation Information
- 10.14.2 Boya Bio Blood Plasma Fractionation Products Offered
- 10.14.3 Boya Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
- 10.14.4 Boya Bio Main Business Overview
- 10.15 Yuanda Shuyang
- 10.15.1 Yuanda Shuyang Corporation Information
- 10.15.2 Yuanda Shuyang Blood Plasma Fractionation Products Offered
- 10.15.3 Yuanda Shuyang Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
- 10.15.4 Yuanda Shuyang Main Business Overview
- 10.16 Weiguang Bio
- 10.16.1 Weiguang Bio Corporation Information
- 10.16.2 Weiguang Bio Blood Plasma Fractionation Products Offered
- 10.16.3 Weiguang Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
- 10.16.4 Weiguang Bio Main Business Overview
- 10.17 Nanyue Bio
- 10.17.1 Nanyue Bio Corporation Information
- 10.17.2 Nanyue Bio Blood Plasma Fractionation Products Offered
- 10.17.3 Nanyue Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
- 10.17.4 Nanyue Bio Main Business Overview
- 10.18 KM Biologics
- 10.18.1 KM Biologics Corporation Information
- 10.18.2 KM Biologics Blood Plasma Fractionation Products Offered
- 10.18.3 KM Biologics Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021)
- 10.18.4 KM Biologics Main Business Overview
- 10.18.5 KM Biologics Recent Development
11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
- 11.1 Blood Plasma Fractionation Key Raw Materials
- 11.1.1 Key Raw Materials
- 11.1.2 Raw Materials Key Suppliers
- 11.2 Manufacturing Cost Structure
- 11.2.1 Raw Materials
- 11.2.2 Labor Cost
- 11.2.3 Manufacturing Expenses
- 11.3 Manufacturing Process Analysis of Blood Plasma Fractionation
- 11.4 Blood Plasma Fractionation Industrial Chain Analysis
- 11.5 Blood Plasma Fractionation Market Dynamics
- 11.5.1 Industry Trends
- 11.5.2 Market Drivers
- 11.5.3 Market Challenges
- 11.5.4 Market Restraints
12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS
- 12.1 Sales Channel
- 12.2 Blood Plasma Fractionation Distributors
- 12.3 Blood Plasma Fractionation Downstream Customers
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.2 Author Details
- 14.3 Disclaimer 148